Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa

How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa

Our client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio. To achieve this, we needed to conduct an in-depth exploration of attitudes and behaviours of people living with HIV. However, stigma surrounding HIV in South Africa meant that respondents may have been unwilling to participate in a traditional interview. Even if they did, it was felt unlikely they would be open to direct questioning. We needed a different approach if we wanted to build a complete picture of life with HIV for our client.

read more »

How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space

How a combined qual quant approach provided our client with integral insights for continued product development in the HIV space

Our client was looking to develop novel HIV prevention products, and wanted to explore different formulation options.

They wanted to learn both the reactions to the novel formulations as well as the impact of out-of-pocket (OOP) costs. Research was required to explore physician and consumer interest and gauge the impact of these developments on new and existing products. 

read more »

Are dual ARVs the new frontier in a maturing HIV market?

Are dual ARVs the new frontier in a maturing HIV market?

Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.

Therapy Watch Associate Director Raquel Nuñez, discusses continuing improvements in HIV therapies and the evolution of single-tablet regimens (STRs) over time.

read more »

Infographic: HIV

Infographic: HIV

Our latest HIV market snapshot, reveals that 2 in 3 patients are currently treated with an STR (Single-tablet regimen) and more than half are treated with InSTIs (Integrase strand transfer inhibitors). Therapy Watch HIV patient data is collected bi-monthly from a panel of 225 physicians across the main 5 EU markets.

read more »

How buyer insights supported the development of an effective market strategy

Our client was developing a new product for HIV and needed to understand buyer willingness to pay in the emerging markets of South Africa, Kenya, and India. They needed to understand how new medicines are added to the guidelines and how they are evaluated and funded. They also needed to gain an understanding of stakeholders’ reactions to their product, the drivers and barriers to use and expectations regarding pricing.

read more »